ArticleUltrasonics sonochemistry2025
Ultrasound-assisted fermentation and microencapsulation of corn gluten meal-rice bran mixture enhance nutritional quality, bioactive stability, and gut delivery.
Article in Ultrasonics sonochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Ultrasonic Regulation of Wheat Flour Product Quality: Mechanisms, Multi-Scale Effects, and Synergistic Technologies.Comprehensive reviews in food science and food safety · 2026Review
- Research Progress Review on the Activation of Bioactive Substances by Targeted Fermentation of Rice Bran.Foods (Basel, Switzerland) · 2026Review
- Coencapsulation of MultistrainInternational journal of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corn gluten meal and rice bran mixture (CRM) are major agricultural by-products of food processing. The nutritional quality of fermented CRM (FCRM) was enhanced through ultrasound-assisted fermentation with Aspergillus oryzae AOX and Lactobacillus helveticus LHS. Additionally, polydopamine/chitosan-gum Arabic/FCRM (P-C-FCRM) microcapsules were fabricated under ultrasonic conditions to enhance the stability of bioactive compounds. After ultrasound-assisted fermentation, high-molecular-weight proteins, zein, and fibers in FCRM were significantly degraded, resulting in 3.32-, 1.42-, and 11.87-fold increases in peptides, total free amino acids, and reducing sugars, respectively, while levels of bioactive compounds-including phenolics, flavonoids, and carotenoids-were also markedly elevated. P-C-FCRM achieved 95.47% encapsulation efficiency and exhibited excellent storage stability. In vitro simulated digestion experiments demonstrated that the degradation rate of unencapsulated FCRM was 59.17%, whereas that of P-C-FCRM was 20.31%, enabling the targeted release of P-C-FCRM in the intestine. Furthermore, in vivo experiments were conducted to examine the regulatory effects of P-C-FCRM on the gut microbiota of chicks. In vivo studies demonstrated that P-C-FCRM improved chick growth and gut health by increasing probiotics and short-chain fatty acids. This work introduces a scalable bioprocess integrating ultrasound, microbial fermentation, and microencapsulation, offering a novel strategy for the valorization of agricultural by-products into value-added functional feed products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.